U.S. News has again ranked CHLA as the top children’s hospital in California and in the survey’s Pacific U.S. region—which encompasses Alaska, California, Hawaii, Oregon and Washington. CHLA also made the publication’s annual Honor Roll of Best Children’s Hospitals for the 14th consecutive year—every year since its inception—finishing No. 8 in the United States in this showcase of the nation’s leading destinations for pediatric medical care.
Stanley C. Jordan, MD, director of the Cedars-Sinai Nephrology and Transplant Immunology programs in the Cedars-Sinai Comprehensive Transplant Center, has been elected to the Association of American Physicians (AAP).
Due to COVID-19 and a rapidly expanding list of conditions for which lung transplantation can be lifesaving, the need for new organs is growing. However, there’s a global shortage of donated lungs, which results in numerous deaths among patients on the waitlist. To help expand the donor pool, Northwestern Medicine is now using a device from XVIVO called XPS™ which is used for ex vivo lung perfusion (EVLP) – nicknamed “lungs in a box” – to rescue potentially viable lungs and those initially deemed “unacceptable” for transplant. Out of all solid organs, lungs have the lowest utilization, with only one in five donated lungs getting transplanted.
Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.
Article title: Rapid postmortem ventilation improves donor lung viability by extending the tolerable warm ischemic time after cardiac death in mice Authors: Junyi Yu, Che Xu, Janet S. Lee, Jonathan K. Alder, Zongmei Wen, Guifang Wang, Agustin Alejandro Gil Silva,…
— The American Society of Nephrology (ASN) re- affirms its supporti for the Organ Procurement Organizations (OPOs) Conditions for Coverage final rule issued on November 20, 2020. The society calls for the Biden-Harris administration to implement this final policy as expediently as possible. By bringing objective and verifiable standards to assess the performance of OPOs, this final rule will increase the number of organs available for transplant and reduce racial inequity in the U.S. transplant system.
People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19.
UC San Diego Health’s lung, heart, kidney and liver transplant programs rank at the top nationally in the latest biannual Scientific Registry of Transplant Recipients (SRTR) report. Innovative treatment and multi-disciplinary care contribute to the high rankings for one-year survival outcomes.
In a year rocked by the COVID-19 (coronavirus) pandemic, the Cedars-Sinai Comprehensive Transplant Center is on track to match or break records.
A multi-institutional study finds that COVID-19 can be found in post-mortem corneal tissue, highlighting the importance of the donor screening process.
A new national policy was created to make determining who receives a heart transplant more fair. But new data shows it changed some practice patterns, too.
A new study analyzes death risk from COVID-19 in organ transplant recipients and finds one treatment method greatly increased the risk.
With more than 109,000 people on the transplant waiting list nationwide, the need for organ donors remains great. A Penn State Health transplant surgeon explains how donors and recipients are kept safe during the COVID-19 pandemic.
Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team from Roswell Park reports in the journal Biology of Blood and Marrow Transplantation.
Researchers at The Ohio State University College of Medicine are the first to identify an immune cell that may predict a transplant patient’s risk of developing antibodies that can cause organ rejection. This discovery could lead to the development of therapies to prevent complications after transplant surgery.
For the first time, surgeons at Northwestern Medicine performed a double-lung transplant on a patient whose lungs were damaged by COVID-19. The patient, a Hispanic woman in her 20s, spent six weeks in the COVID ICU on a ventilator and extracorporeal membrane oxygenation (ECMO), a life support machine that does the work of the heart and lungs.